TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/12/2025
Voltar para busca
Dado oficial do USPTO
UNLEARN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
17/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
11/03/2020
Data de registro
06/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/10/2020
Última transação
17/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
2019-04-00
Primeiro uso no comércio
2019-04-00
Código do desenho
4
Tipo de titular
03
Localização do titular
San Francisco, CA
Examinador
MONDELL, DOUGLAS
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
UNLEARN.AI, INC.
Representantes
Isaac M. Fine KPPB LLP
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
business consulting and management in the fields of medical researchpharmaceutical development and clinical trials for business purposes; business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of pharmaceutical developmentmanagement and compilation of computerized databases in the field of pharmaceutical development for business purposes; business consulting and management in the field of pharmaceutical developmentmanagement and compilation of computerized databases in the field of medical research for business purposes
Classe 42
providing medical and scientific research information in the fields of medical researchpharmaceutical development and clinical trials; consulting services for others in the field of design and planning of clinical trials; consulting services for others in the fields of medical research and pharmaceutical development; consulting services for others in the fields of medical research and pharmaceutical developmentproviding digital models of patients for use as simulated control subjects; consulting services for others in the field of design and planning of clinical trialsproviding digital models of patients for use as simulated control subjects for clinical trials; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in the design and planning of clinical trials; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in medical research and pharmaceutical development; providing data analytics and artificial intelligence in the nature of providing temporary use of online non-downloadable software for use in the life sciences field for the purpose of researchdevelopmentcommercialization; providing temporary use of on-line non-downloadable cloud computing software for managinggatheringgeneratingorganizingsharing data in the fields of pharmaceutical developmentmedical clinical trials and medical research; providing temporary use of on-line non-downloadable cloud computing software for designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocols; providing temporary use of on-line non-downloadable cloud computing software for designingmanagingexecuting pharmaceutical development research; providing a website featuring educational information in the fields of medical researchpharmaceutical developmentclinical trials and artificial intelligence
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/10/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
22/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/04/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
17/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/07/2020
PUBO
PUBLISHED FOR OPPOSITION
21/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
08/06/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
08/06/2020
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
08/06/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
08/06/2020
DOCK
ASSIGNED TO EXAMINER
02/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/03/2020
NWAP
NEW APPLICATION ENTERED
14/03/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UNLEARN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.